Clinical Trial of the Use of the Nasal Spray of Patients With Recurrence of Glioblastoma
Status:
Withdrawn
Trial end date:
2018-07-17
Target enrollment:
Participant gender:
Summary
This is a study to determine the efficacy, safety and clinical benefit (how well the drugs
works), of the pharmaceutical compositions in Nasal Spray NST-4G for the treatment of brain
tumors( Recurrent Glioblastoma, Gliosarcoma,Anaplastic Gliomas, Previously Treated).
All drugs target the inhibition of the growth factors and neo-angiogenesis as one the main
reasons for the growth of the tumor.
The purpose of the Nasal Spray NST-4G study is to determine the safety and tolerability in
order to establish the best dose level to be used in future studies.